Shorts

Andreas Pollreisz, MD, encourages taking a second look with OCT-A
0:37
Andreas Pollreisz, MD, encourages taking a second look with OCT-A
19 days ago
by
Andreas Pollreisz, MD(+1 more)
Sofia Androudi on retinal disorders mimicking inherited retinal diseases
0:43
Sofia Androudi on retinal disorders mimicking inherited retinal diseases
19 days ago
by
Sofia Androudi, MD(+1 more)
Elon van Dijk on central serous chorioretinopathy
0:43
Elon van Dijk on central serous chorioretinopathy
19 days ago
by
Elon van Dijk(+1 more)
Timothy Lai discusses the SALWEEN 1-year data
0:50
Timothy Lai discusses the SALWEEN 1-year data
19 days ago
by
Timothy Lai(+2 more)
Giuseppe Querques, MD, PhD, sheds light on two challenging pathophysiologies at EURETINA
0:37
Giuseppe Querques, MD, PhD, sheds light on two challenging pathophysiologies at EURETINA
19 days ago
by
Giuseppe Querques, MD, PhD(+1 more)
Why the current staging for diabetic eye disease is obsolete
0:49
Why the current staging for diabetic eye disease is obsolete
19 days ago
by
Stela Vujosevic, MD, PhD, FEBO(+2 more)

Podcasts

(Image credit: Modern Retina) Eichenbaum Acorns: A leadership conversation with Rishi P. Singh, MD, FASRS, on advancing CME

Eichenbaum Acorns: A leadership conversation with Rishi P. Singh, MD, FASRS, on advancing CME

Behind the scenes of building impactful educational platforms in retina care

The Retina TL;DR: Rethinking retinal detachment repair with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD

The Retina TL;DR: Rethinking retinal detachment repair with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD

In the debut episode of The Retina TL;DR, host Christina Y. Weng, MD, MBA, FASRS, talks with Tony Stefater, MD, PhD; and Tommy Stryjewski, MD, about PYK-2101, a biodegradable retinal sealant designed to replace gas and oil tamponades.

PHOTON Trial Outcomes: Impact on DME Patient Care in Clinical Practice

PHOTON Trial Outcomes: Impact on DME Patient Care in Clinical Practice

John Kitchens, MD, and Diana Do, MD, delve into the PHOTON trial results and their significance for treating patients with diabetic macular edema in clinical settings.

PULSAR Study Findings: Implications for Treating Neovascular Age-Related Macular Degeneration (nAMD) in Clinical Practice

PULSAR Study Findings: Implications for Treating nAMD in Clinical Practice

Join John Kitchens, MD, and David Brown, MD, as they explore the PULSAR study results and their impact on managing neovascular age-related macular degeneration in your practice.

Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.

What to expect from virtual AAO 2020

What to expect from virtual AAO 2020

American Academy of Ophthalmology (AAO) President Anne L. Coleman, MD, PhD, offers a preview of what attendees can look forward to from the academy's 2020 virtual annual meeting — kicking off Nov. 13-15.

Spotlighting telemedicine in the year of a pandemic

Spotlighting telemedicine in the year of a pandemic

In this EyePod episode, Ranya Habash, MD, of Bascom Palmer Eye Institute, University of Miami, speaks on the expansion of telemedicine in ophthalmology amid the pandemic and why the future of telemedicine requires a new way of thinking.

Putting in practice retina innovations amid a pandemic

Putting in practice retina innovations amid a pandemic

S.K. Steven Houston III, MD, shares how his practice has put to use recent retina innovations and adapted to accommodate the ever-changing operating room spacing and set-up in the current COVID-19 environment.

EyePod

ASRS 2020: Evaluating 3-year-recurrence rate in non-infectious posterior segment uveitis post-FAi

Dilraj Grewal, MD, associate professor of ophthalmology at Duke Eye Center/ director of grading at the Duke Reading Center, speaks on his presentation "Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis Following an Injectable Fluocinolone Acetonide Insert," during the virtual 2020 ASRS meeting.



Modern Retina Digital Edition


Continuing Medical Education


All News